ADB Downgrades India's Economic Projection To 10% For 2021
The Asian Development Bank (ADB) lowered India's economic growth forecast to 10 per cent from 11 per cent for 2021- down by one percentage point, following the severe second wave of COVID-19 pandemic in the country. In its latest economic outlook report, the multilateral funding agency said that the spike in the number of COVID-19 cases during the second wave of the pandemic affected economic recovery.Â
"The outbreak, however, dissipated faster than anticipated, resulting in several states easing lockdown measures and returning to more normal travel patterns,'' said ADB in its report. However, India's economic growth outlook for next year has improved to 7.5 per cent from seven per cent.
The regional development bank lowered its 2021 economic growth outlook for developing Asia due to COVID-related concerns in the countries. It projects a growth of 7.1 per cent this year, compared to a projection of 7.3 per cent made in April this year.
For 2022, the growth outlook is raised to 5.4 per cent from 5.3 per cent, according to ADB. New variants of COVID-19, the reinstatement of various levels of lockdown restrictions, renewed local outbreaks, and slow, uneven vaccine rollouts are weighing down the region's growth prospects.
Earlier in the year, the International Monetary Fund (IMF) downgraded India's growth projection from 12.5 per cent to 9.5 per cent for the current fiscal 2021-22 - down by three percentage points, due to the impact of the second wave of COVID-19 in the country. For the current financial year, India registered the largest drop in growth projections made by IMF, even as the global economic growth rate was retained at six per cent.Â
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.